PX1 Research offers laboratory-grade Chonluten (Glu-Asp-Gly) synthesized for in vitro and animal models investigating bronchial epithelial cellular signaling and bioactive substance secretion. Every batch undergoes rigorous RP-HPLC and mass spectrometry testing to guarantee structural identity, purity, and minimal endotoxin levels. Designed exclusively for qualified researchers and academic institutions, our research peptides ship directly from US-based facilities with lot-specific certificates of analysis.
PX1 Research offers laboratory-grade Chonluten (Glu-Asp-Gly) synthesized for in vitro and animal models investigating bronchial epithelial cellular signaling and bioactive substance secretion. Every batch undergoes rigorous RP-HPLC and mass spectrometry testing to guarantee structural identity, purity, and minimal endotoxin levels. Designed exclusively for qualified researchers and academic institutions, our research peptides ship directly from US-based facilities with lot-specific certificates of analysis.
If your institution is seeking to buy bioactive substance secretion Chonluten for sale, PX1 Research provides analytical-grade L-glutamyl-L-aspartyl-glycine (Glu-Asp-Gly) synthesized under strict ISO 17025 laboratory protocols. Formulated exclusively for in vitro and preclinical research applications, our Chonluten is batch-verified via High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to exceed 98% purity, accompanied by lot-traceable certificates of analysis.
Chonluten is a short synthetic bioregulatory tripeptide primarily investigated for its role in modulating bronchial epithelial gene expression, mucin production, and cytokine release. As a cornerstone peptide in respiratory cell biology assays, acquiring verified, low-endotoxin Chonluten is critical for avoiding baseline artifactual inflammation in cell culture and animal tissue models. Researchers can explore our full catalog of research peptides or inspect specific product data sheets directly through our store.
Chonluten is a short-chain peptide composed of three amino acid residues: L-glutamic acid, L-aspartic acid, and glycine. Designated chemically as Glu-Asp-Gly, this tripeptide belongs to the Khavinson class of short peptide bioregulators. Its low molecular weight (approximately 305.24 g/mol) allows it to interact with specific nucleosomal domains and cell-surface receptors without triggering steric hindrance typically associated with larger polypeptides.
In chemical structure assays, the carboxylic side chains of glutamic and aspartic acids impart a distinctly acidic residue profile, which is thought to mediate ionic interactions with histones and specific DNA sequences. In vitro studies utilize this distinct primary sequence to evaluate how short peptide chains cross nuclear envelopes and modulate epigenetic mechanisms regulating structural protein synthesis. Detailed sequence analysis and analytical data are accessible via our PX1 research repository.
Preclinical investigations suggest that Chonluten exerts its regulatory effects by penetrating target cells and binding to promoter region motifs on DNA. In bronchial epithelial cell cultures, this interaction appears to alter chromatin condensation, thereby modulating the transcription rates of genes responsible for maintaining mucosal homeostasis and surfactant production.
In vitro data indicate that Chonluten specifically influences the secretion of bioactive substances—such as secretory immunoglobulin A (sIgA), mucin glycoproteins (MUC5AC and MUC5B), and endogenous anti-inflammatory cytokines. Rather than universally upregulating protein synthesis, the peptide appears to exhibit a homeostatic effect, normalizing baseline protein expression in damaged or stress-induced cellular models. Investigators evaluating non-respiratory signaling cascades can cross-reference these mechanisms with broader cellular models detailed under our Khavinson bioregulator peptides scientific review.
Published literature in animal models of inflammatory lung injury demonstrates that administration of Chonluten restores normal bronchial secretory dynamics. In rodent models exposed to toxic inhalants or pathogenic mimics (such as lipopolysaccharides), Chonluten treatment was observed to suppress excessive pro-inflammatory interleukin (IL-6, IL-8, TNF-alpha) production while preserving mucosal barrier proteins.
Furthermore, organotypic tissue culture assays reveal that Chonluten supports ciliary beat frequency and mucus clearance rates by modulating fluid and electrolyte transport channels across the apical membrane of respiratory epithelial cells. Researchers seeking to replicate these preclinical findings depend on consistent peptide peptide folding, purity, and exact sequence verification to prevent false-positive inflammatory responses triggered by synthetic impurities.
Beyond secretion regulation, Chonluten is widely studied in cellular senescence and apoptosis models. When bronchial fibroblasts and epithelial cells are subjected to oxidative stress or hyperoxic conditions, the presence of Chonluten in culture media correlates with reduced reactive oxygen species (ROS) accumulation and upregulation of endogenous antioxidant enzymes such as superoxide dismutase (SOD) and catalase.
In vitro scratch assays demonstrate accelerated wound closure rates in human primary bronchial epithelial monolayer cultures treated with micro-molar concentrations of Chonluten. These findings suggest that the tripeptide stimulates localized tissue regeneration by enhancing cell migration and cellular matrix protein deposition, providing a solid foundation for further investigations into structural respiratory remodeling.
To ensure reproducible quantitative data in scientific assays, research peptides must adhere to stringent analytical purity thresholds. PX1 Research subjects every synthesis lot of Chonluten to rigorous quality control processes in ISO 17025 accredited facilities located in the United States. We utilize Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm chemical purity levels above 98% and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify exact molecular mass.
Because Chonluten is frequently evaluated in sensitive cytokine secretion assays, controlling bacterial endotoxin levels is essential. Gram-negative lipopolysaccharides (LPS) can falsely trigger pro-inflammatory signaling pathways, invalidating experimental outcomes. PX1 Research performs quantitative Chromogenic LAL (Limulus Amebocyte Lysate) assays on every batch, guaranteeing endotoxin levels fall below strict laboratory thresholds (<0.05 EU/mg). Every shipment includes a lot-specific Certificate of Analysis (COA) for full experimental transparency.
When designing cell signaling and secretory experiments, investigators frequently compare Chonluten against other Khavinson peptide candidates targeting epithelial or immune pathways. For instance, Bronchogen (Ala-Glu-Asp-Leu) is another respiratory-focused tetrapeptide often evaluated alongside Chonluten to compare structural differences in mucosal gene expression. Similarly, researchers exploring broader immune modulation and systemic homeostatic pathways often cross-reference Epithalon (Ala-Glu-Asp-Gly) or examine Thymalin for T-cell differentiation models.
While Bronchogen primarily targets structural bronchial remodeling, Chonluten demonstrates specialized activity in modulating cellular secretion dynamics and apical transport mechanisms. Utilizing validated peptides from the same synthetic pipeline ensures consistent molar comparisons across multi-peptide screening panels.
Chonluten is supplied as a lyophilized (freeze-dried) powder to maximize shelf stability. To maintain structural integrity during laboratory handling, vials should be stored at -20°C upon receipt. Prior to reconstitution, vials should be allowed to equilibrate to room temperature to prevent condensation from introducing moisture into the cake.
For solubilization, researchers typically reconstitute Chonluten in sterile bacteriostatic water, sterile normal saline (0.9% NaCl), or cell culture compatible buffers such as PBS (phosphate-buffered saline), depending on the requirements of the down-stream assay. Once reconstituted, aliquot the peptide solution into working volumes to prevent repeated freeze-thaw cycles, which degrade peptide bonds over time. Detailed reconstitution parameters can be referenced in our comprehensive laboratory reconstitution guidelines.
PX1 Research caters to academic institutions, biotechnology enterprises, and contract research organizations (CROs) requiring dependable supplies of high-purity research compounds. Whether conducting pilot micro-well plates or long-term multi-animal studies, our supply chain ensures batch-to-batch consistency and complete lot traceability.
We offer streamlined ordering, rapid same-day dispatch from our California and Arizona fulfillment centers, and dedicated account support for bulk laboratory procurement. Researchers seeking custom synthesis runs or high-volume orders can review our bulk lab acquisition program to discuss institutional pricing and technical support.
What is Chonluten used for in laboratory research?
Chonluten (Glu-Asp-Gly) is a research peptide studied in vitro and in preclinical animal models to investigate bronchial epithelial cell dynamics, bioactive substance secretion, mucosal cytokine balance, and epigenetic regulation of structural gene expression.
How is the purity of PX1 Research Chonluten verified?
Every lot of Chonluten supplied by PX1 Research undergoes rigorous testing via Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) for chemical purity and Electrospray Ionization Mass Spectrometry (ESI-MS) for structural identity verification. Testing reports are published in a lot-specific Certificate of Analysis (COA).
What are the endotoxin limits on Chonluten research vials?
PX1 Research verifies that endotoxin levels are maintained below strict analytical limits (<0.05 EU/mg) using Chromogenic LAL testing. Low endotoxin content is critical to prevent artifactual immune activation in sensitive cell culture and secretory assays.
How should lyophilized Chonluten be stored in the lab?
Lyophilized Chonluten should be stored at -20°C for medium-term storage or -80°C for long-term stability. Desiccated vials should be brought to room temperature before opening to minimize atmospheric moisture absorption.
What solvent is recommended for reconstituting Chonluten?
Chonluten solubilizes readily in sterile research-grade water, phosphate-buffered saline (PBS, pH 7.4), or 0.9% normal saline. Choice of solvent depends on the specific requirements of the planned in vitro or ex vivo assay.
How does Chonluten differ from Bronchogen?
Chonluten is a tripeptide (Glu-Asp-Gly), whereas Bronchogen is a tetrapeptide (Ala-Glu-Asp-Leu). While both are studied in respiratory models, preclinical literature indicates slight differences in gene expression target profiles, secretory modulation, and structural mucosal repair mechanisms.
Is Chonluten approved for human use or clinical administration?
No. Chonluten provided by PX1 Research is strictly designated for in vitro, ex vivo, and animal laboratory research use only. It is not for human or veterinary diagnostic, therapeutic, or clinical applications.
Where are PX1 Research compounds manufactured and shipped from?
All PX1 Research compounds are manufactured in state-of-the-art facilities compliant with US quality control standards and shipped directly from our primary distribution hubs in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.